LSE:GSK.L 28 November 2025

GSK stock slips in London as oil shock rattles markets; buyback filing and FDA date in focus

GSK plc slipped 1.1% to 2,177 pence as of 0823 GMT, having moved between 2,172 and 2,194 earlier. The FTSE 100 shed roughly 0.7%. AstraZeneca shares dropped, too.

2 March 2026

LSE:GSK.L·Oil Prices·Stock Market

Why GSK stock is moving today: Exdensur EU nod and a fresh buyback

GSK picked up roughly 1% on Wednesday, after the company announced European Commission approval for its Exdensur treatment—used for asthma and nasal polyps—and kicked off another round of share buybacks. Shares traded at 2,263 pence, up 1.1%.

18 February 2026

EU Regulations·LSE:GSK.L·Pharmaceuticals

GSK share price drops in early London trade as Arexvy China filing and insider sales set the tone

GSK slipped roughly 1.5% to 2,117 pence in early trading Thursday in London, pulling back after a robust run earlier this year. Shares had closed Wednesday at 2,153 pence.

12 February 2026

LSE:GSK.L·Pharmaceuticals·Stock Market

GSK stock price in focus before London open after China starts Arexvy review

GSK plc was on investor watch in pre-market London trade Wednesday following news of new regulatory movement for its RSV vaccine in China. The shares wrapped up Tuesday’s session at 2,168 pence, a 0.42% gain.

11 February 2026

LSE:GSK.L·Stock Market

China’s Arexvy review puts GSK stock back in focus before London trade

GSK plc shares are set to trade with new vaccine developments on the radar. The company reported that China’s Center for Drug Evaluation has taken up its application for Arexvy, the RSV shot designed for people 60 and up. GSK noted that, should approval come through, Arexvy would mark the first vaccine in China targeting RSV-linked lower respiratory tract disease in that demographic.

10 February 2026

LSE:GSK.L·NYSE:GSK·Pharmaceuticals·Stock Market

GSK stock price: EU nod for Nucala in COPD puts the focus on Monday trade

GSK closed Friday at 2,198 pence, up 18 pence, or 0.8%. That puts the drugmaker's valuation near 88 billion pounds. Shares have climbed roughly 17% this week, and they've surged almost 49% over the last year.

8 February 2026

EU Regulations·LSE:GSK.L·Pharmaceuticals·Stock Market

GSK share price set for Monday watch after EU clears Nucala COPD use

Shares of GSK ended Friday up 0.83% at 2,198 pence, a 52-week high, after the drugmaker said the European Commission approved Nucala for a form of chronic obstructive pulmonary disease. The stock is up about 17% over the past week and nearly 49% over the past year.

7 February 2026

LSE:GSK.L·Pharmaceuticals·Stock Market

GSK share price ticks up as cost-cutting talk swirls ahead of Feb. 4 results

Shares of GSK edged higher by 0.3% to 1,882.5 pence as of 0826 GMT, moving within a range of 1,875 to 1,890 pence earlier. Over the last 52 weeks, the stock has fluctuated between 1,242.5 and 1,909.5 pence.

2 February 2026

Earnings Reports·LSE:GSK.L·Pharmaceuticals·Stock Market

GSK share price slips in early London trade as tariff jitters flare — what investors watch next

Shares of GSK plc edged down 0.6% to 1,806 pence by 0802 GMT, marking a subdued opening for the drugmaker in London. The stock fluctuated between 1,796p and 1,809p, staying far from its 52-week peak.

19 January 2026

LSE:AZN.L·LSE:GSK.L·Stock Market

GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

GSK shares were down 0.6% at 1,879.5 pence by 1050 GMT, trading in a 1,871p to 1,886p range.

9 January 2026

Earnings Reports·LSE:GSK.L·Pharmaceuticals·Stock Market

GSK share price slips as hepatitis B drug headline leaves investors wanting the numbers

GSK shares slipped on Thursday as investors weighed upbeat headlines on its experimental hepatitis B therapy against a lack of hard cure-rate data. The stock was down 0.9% at 1,883.5 pence in London trade, after moving between 1,880 and 1,896.5 pence and staying near the top of its 52-week range. Investing.com+1

8 January 2026

LSE:GSK.L·Pharmaceuticals·Stock Market

Most Active UK Stocks Today (9 December 2025): BP, Barclays, Rolls‑Royce, Unilever and More in Focus

After one of the strongest years for London equities in over a decade, trading in the UK stock market is heading into Tuesday 9 December 2025 with a very specific cast of blue-chip names dominating turnover.

9 December 2025

LSE:AAL.L·LSE:BARC.L·LSE:BATS.L·LSE:BP.L·LSE:GSK.L·LSE:HSBA.L·LSE:LLOY.L·LSE:RR.L·LSE:ULVR.L·Stock Market·UK Stocks

Best UK Stocks to Buy Today (8 December 2025): 7 FTSE 100 Ideas for a Potential Rate‑Cut Era

The UK stock market has quietly turned into one of 2025’s star performers. The FTSE 100 is trading around 9,660 and has delivered a total return of roughly 20–23% year‑to‑date, one of its best years since the aftermath of the financial crisis.Investors Chronicle+2Wealth DFM+2

8 December 2025

FTSE 100·LSE:AZN.L·LSE:BP.L·LSE:DGE.L·LSE:GSK.L·LSE:HSBA.L·LSE:SHEL.L·LSE:ULVR.L·Stock Market·UK Economy

GSK plc Stock Today, 28 November 2025: Buybacks, ‘Hold’ Ratings and Pipeline Momentum Keep Shares Near Highs

GSK plc is drifting quietly higher on Friday, 28 November 2025, with investors digesting a fresh “Hold” consensus from Wall Street, another round of share buybacks and a still‑busy drug pipeline that has pushed the stock close to 12‑month highs.

28 November 2025

LSE:GSK.L·Pharmaceuticals·Stock Market

LSE:GSK.L 28 November 2025 - 2 March 2026